Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Intensity Therapeutics, Inc.

NASDAQ: INTS · Life Sciences · 3 alerts · CIK 1567264

Share price
$3.07Close, Nov 16
Market cap
$10.1M
Shares outstanding
3.3MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Intensity Therapeutics, Inc. filings on SEC EDGAR ↗

7:40 AM ET 10-Q
Financial Results ▶ Call

Intensity Therapeutics Q3 2026 Results: Net Loss of $3.54M, Loss Widens

Intensity Therapeutics reported a net loss of $9.0 million for the nine months ended September 30, 2026, compared to $8.6 million in the prior year period. The company's cash position decreased to $8.5 million from $11.9 million at year-end 2025, primarily due to ongoing research and development expenses for its lead drug candidate, INT230-6.

Key figure
Net loss $3.54M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.